Clinical Trials Logo

Filter by:
NCT ID: NCT04682977 Completed - Clinical trials for Uncontrolled Diabetes (HBA1c = 10)

Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline

Start date: April 22, 2021
Phase: N/A
Study type: Interventional

Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.

NCT ID: NCT04682730 Completed - Clinical trials for Pit-and-Fissure Sealants

An Implementation Strategy for the Adoption of an Evidence-Based Guideline for Pit-and-Fissure Sealants

DISGO
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The purpose of this implementation science study is to determine whether Deliberative Loops are effective in increasing providers' adherence to the non-cavitated caries component of the American Dental Association's pit-and-fissure sealant evidence-based clinical practice guideline. The investigators use a stepped wedge design to randomly assign dental clinics to the Deliberative Loop intervention. In a Deliberative Loop, stakeholders receive background information, participate in a facilitated discussion, and share their views with leadership. The Deliberative Loop intervention is designed to help stakeholders form informed opinions; in this study, stakeholders will be forming informed opinions about the implementation interventions they think will increase their clinic's adherence to the guideline. The investigators hypothesize that compared with the pre-intervention period, following the intervention, providers will place or treatment plan sealants for significantly more occlusal non-cavitated carious lesions.

NCT ID: NCT04682639 Completed - Clinical trials for Eosinophilic Esophagitis

A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis

VOYAGE
Start date: December 15, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for active eosinophilic esophagitis (EoE) in adult participants.

NCT ID: NCT04682587 Completed - Clinical trials for Renal Cell Carcinoma

To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma

Start date: February 24, 2021
Phase:
Study type: Observational

To assess how dose reductions or treatment interruptions related to axitinib can be implemented to manage and resolve adverse events occurring among patients with advanced renal cell carcinoma treated with first-line axitinib in combination with avelumab or pembrolizumab

NCT ID: NCT04682548 Completed - Multiple Sclerosis Clinical Trials

Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients

Start date: January 5, 2021
Phase:
Study type: Observational

This non-interventional, biospecimen collection study is designed to help us better understand whether MS patients have impaired immune defenses to COVID-19 infection. The potential influence of immune modulating medications for MS will be considered through these exploratory studies. This study is also designed to provide context for interpretation of anti-SARS CoV2 serologies in MS patients during convalescence from COVID-19 infection.

NCT ID: NCT04682535 Completed - Dementia Clinical Trials

Daily Study of Caregiving Relationships and Health

Start date: September 1, 2020
Phase:
Study type: Observational

The purpose of the Daily Study of Caregiving Relationships and Health is to learn how caregiving relationships and social connectedness are associated with dementia caregivers' health, health behaviors, and diurnal patterns of salivary cortisol. This is a pilot study wherein the purpose is to test the feasibility and acceptability of study protocols.

NCT ID: NCT04682522 Completed - Crohn Disease Clinical Trials

Flagyl Microbiome in Crohn's Disease

Start date: March 21, 2021
Phase: Phase 4
Study type: Interventional

This study will compare the types of bacteria in the colon before and after colon resection surgery. The investigator will also compare standard post-operative antibiotic treatment to flagyl (metronidazole) treatment post-operatively to see if giving the antibiotic, decreases the incidence of return of Crohn's disease.

NCT ID: NCT04682405 Completed - Multiple Myeloma Clinical Trials

Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM)

Start date: May 5, 2021
Phase: Phase 2
Study type: Interventional

The investigators hypothesize that prophylactic E-selectin inhibition via administration of uproleselan during melphalan conditioning will reduce the gastrointestinal (GI) toxicity in multiple myeloma (MM) patients undergoing auto-transplant, as assessed via diarrhea severity scoring per CTCAE v5.0, while potentially increasing chemosensitivity of malignant MM cells to high-dose melphalan.

NCT ID: NCT04682353 Completed - Contraception Clinical Trials

A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age

Start date: December 14, 2020
Phase: Phase 1
Study type: Interventional

The primary objective of this study is to evaluate and compare the pharmacokinetic profile of Medroxyprogesterone acetate following subcutaneous administration of 3 different doses of TV-46046 and a dose of Depo-subQ Provera in healthy female participants. The secondary objectives of the study are to evaluate and compare the safety, local tolerability, and acceptability of a subcutaneous injection of 3 different doses of TV-46046 and a dose of Depo-subQ Provera in healthy female participants. The total duration of the study for each participant is expected to be up to 19.5 months.

NCT ID: NCT04682301 Completed - Lung Carcinoma Clinical Trials

Tailoring Shared Decision Making for Lung Cancer Screening in Persons Living With HIV

Start date: February 5, 2021
Phase:
Study type: Observational

This study tailors a shared decision making intervention for lung cancer screening in persons living with human immunodeficiency virus (HIV). Information collected in this study may help doctors better understand how to perform lung cancer screening in persons living with HIV, so as to enhance shared decision making in persons living with HIV.